인슐린 펌프 시장 보고서 : 제품 유형, 유통 채널, 지역별(2025-2033년)

The global insulin pumps market size reached USD 5.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is driven by the increasing number of people with diabetes, the rising incomes of individuals, the growing awareness about the benefits of the product, and the growing spending on healthcare.

Insulin pumps are small computerized medical devices that can be clipped on to a belt, pocket or hidden under the clothes. The pump is used to deliver controlled doses of insulin inside the body at regular intervals, depending upon the consumer's basal and bolus rate, to control the rise in blood glucose levels. It operates through a needle and a flexible catheter that is used to insert insulin directly into the fatty tissue, which is then taped and secured in place. Insulin pumps assist individuals suffering from type 1 and type 2 diabetes by providing them flexibility in food options and eating schedules and reduces the number of injection administrations.

The increasing prevalence of diabetes across the globe and rising health awareness are the key factors for market growth. Modernization of economies has significantly enhanced the occurrence of several lifestyle diseases, especially diabetes. This is further augmented by changing dietary preferences and dependency on ready-to-eat packaged food containing artificial ingredients and preservatives. Since diabetes can trigger the occurrence of other chronic conditions such as kidney failure, stroke, paralysis and blindness, manufacturers are increasingly emphasizing on creating adaptive and affordable devices. Additionally, due to the development of highly accurate glucose sensors and blood monitoring devices, the demand for efficient insulin pumps has also increased. Furthermore, factors such as rising per capita expenditure on healthcare services and increasing research and development for improving the functioning of insulin pumps have also contributed to market growth.

Insulin Pumps Industry Segmentation:

Breakup by Product Type:

Insulin Pumps

Tethered Pumps

Disposable/Patch Insulin Pumps

Insulin Pump Supplies and Accessories

Infusion Set Insertion Devices

Insulin Reservoirs/Cartridges

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Sales

Diabetes Clinics/ Centers

Others

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being EOFlow Co. Ltd., Insulet Corp., Medtronic plc, MicroPort Scientific Corporation., Microtech Medical, Roche Diabetes Care Limited, Sooil Development Co. Ltd., Tandem Diabetes Care Inc., Terumo Europe NV (Terumo Corporation), Ypsomed, etc.

Key Questions Answered in This Report

• 1. What was the size of the global insulin pumps market in 2024?
• 2. What is the expected growth rate of the global insulin pumps market during 2025-2033?
• 3. What are the key factors driving the global insulin pumps market?
• 4. What has been the impact of COVID-19 on the global insulin pumps market?
• 5. What is the breakup of the global insulin pumps market based on the product type?
• 6. What is the breakup of the global insulin pumps market based on the distribution channel?
• 7. What are the key regions in the global insulin pumps market?
• 8. Who are the key players/companies in the global insulin pumps market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Insulin Pumps Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Product Type
• 5.5 Market Breakup by Distribution Channel
• 5.6 Market Breakup by Region
• 5.7 Market Forecast

6 Market Breakup by Product Type

• 6.1 Insulin Pumps
  • 6.1.1 Market Trends
  • 6.1.2 Market Breakup by Type
    • 6.1.2.1 Tethered Pumps
      • 6.1.2.1.1 Market Trends
      • 6.1.2.1.2 Market Forecast
    • 6.1.2.2 Disposable/Patch Insulin Pumps
      • 6.1.2.2.1 Market Trends
      • 6.1.2.2.2 Market Forecast
  • 6.1.3 Market Forecast
• 6.2 Insulin Pump Supplies and Accessories
  • 6.2.1 Market Trends
  • 6.2.2 Market Breakup by Type
    • 6.2.2.1 Insulin Reservoirs/Cartridges
      • 6.2.2.1.1 Market Trends
      • 6.2.2.1.2 Market Forecast
    • 6.2.2.2 Infusion Set Insertion Devices
      • 6.2.2.2.1 Market Trends
      • 6.2.2.2.2 Market Forecast
  • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

• 7.1 Hospital Pharmacy
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Retail Pharmacy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Online Sales
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Diabetes Clinics/ Centers
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Europe
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Asia Pacific
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Middle East and Africa
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Latin America
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 EOFlow Co. Ltd.
  • 13.3.2 Insulet Corp.
  • 13.3.3 Medtronic plc
  • 13.3.4 MicroPort Scientific Corporation.
  • 13.3.5 Microtech Medical
  • 13.3.6 Roche Diabetes Care Limited
  • 13.3.7 Sooil Development Co. Ltd.
  • 13.3.8 Tandem Diabetes Care Inc.
  • 13.3.9 Terumo Europe NV (Terumo Corporation)
  • 13.3.10 Ypsomed